Premium
Genetic profiling of basal cell carcinomas detects postzygotic mosaicism in basal cell naevus syndrome
Author(s) -
Reinders M.G.H.C.,
Cosgun B.,
Gijezen L.M.C.,
Oosterhoud C.N.,
KellenersSmeets N.W.J.,
Vermander E.,
Vreeburg M.,
Steijlen P.M.,
Mosterd K.,
Geel M.
Publication year - 2019
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.17337
Subject(s) - biology , ptch1 , germline mutation , germline , basal cell nevus syndrome , genetics , germline mosaicism , mutation , basal cell carcinoma , gene , basal cell , pathology , medicine , hedgehog signaling pathway
Summary Basal cell naevus syndrome ( BCNS ) is associated with germline mutations in the PTCH 1 gene. Postzygotic mosaicism can also cause BCNS . Here we describe two patients, one with multiple basal cell carcinomas ( BCC s) and one with clinical BCNS , who had no PTCH 1 mutation in DNA extracted from blood. In both patients, we performed genetic analysis on different BCC s, revealing the presence of a shared PTCH 1 mutation in all tumours. Our findings show that in patients with symptoms of BCNS and initial absence of a PTCH 1 mutation in blood, genetic profiling of BCC s can detect postzygotic mosaicism.What's already known about this topic?Basal cell naevus syndrome (BCNS) is associated with germline mutations in the PTCH1 gene, but it can also be caused by low‐grade postzygotic mosaicism in PTCH1 .What does this study add?In patients suspected of having BCNS or patients with multiple basal cell carcinomas (BCCs) with a special distribution on the body and no mutation detected in blood, it is worthwhile to search for a shared PTCH1 mutation in their BCCs as this can detect postzygotic mosaicism. This information is important to ensure proper surveillance programmes, choose the right therapy and provide adequate genetic counselling.